Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-56.09	145.97	332.42
Graham Fair Price	-71.53	0.78	2.74
PEG	14355.28	-0.47	< 0.005
Price/Book	-15.17	2.98	3.51
Price/Cash Flow	-15.99	178.48	212.45
Prices/Earnings	991.89	50.25	-4.60
Price/Sales	-23.15	21.31	27.73
Price/FCF	-15.99	178.48	212.45
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.60	0.41	0.44
Operating Margin	-91.49	0.14	-1.61
ROA	-92.25	0.01	-0.15
ROE	-0.19	0.01	-92.23
ROIC	-0.18	0.02	-91.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	0.03	81.57
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-13.16	1.10	-91.68
EPS QOQ	-14.30	1.08	-92.45
FCF QOQ	-0.36	0.03	-92.91
Revenue QOQ	< 0.005	0.12	1231.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	8.58	6.74	-21.48
Days Sales Outstanding (DSO)	56.30	34.90	-38.01
Inventory Turnover	10.49	13.36	27.35
Debt/Capitalization	0.03	0.03	-6.94
Quick Ratio	2.48	2.38	-4.21
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.32	1.35	2.14
Cash	0.54	0.57	5.65
Capex	< 0.005	< 0.005	-114.85
Free Cash Flow	0.02	0.02	3.13
Revenue	0.17	0.19	12.73
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.54	2.59	1.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-16.74	-10.22	38.98
Naive Interpretation	Member

06 - Financial Health · Bad

Rating